CS logo
small CS logo
Boston Center for Memory

Newton, Massachusetts, United States
Neurologist in Newton, Massachusetts
180 Wells Ave Suite #304, Newton, MA 02459

About Boston Center for Memory


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
8
Biogen
4
Hoffmann-La Roche
3
AstraZeneca
2
Avid Radiopharmaceuticals
2
Cognito Therapeutics, Inc.
2
Neuronetrix, Inc.
2
Otsuka Pharmaceutical Development & Commercialization, Inc.
2
Alector Inc.
1
Athira Pharma
1
Cassava Sciences, Inc.
1
Total Rows: 12

Clinical Trials at Boston Center for Memory


During the past decade, Boston Center for Memory conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 11 clinical trials were completed, i.e. on average, 44% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33333355114455110000001122113344Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
2010-12-01
2014-02-01
Completed
204
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
2010-11-30
2020-09-10
Completed
799
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
2013-07-01
2017-02-01
Terminated
2,129
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
2014-09-30
2018-10-04
Terminated
2,218
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type
2015-11-11
2019-09-09
Completed
522
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
2015-12-01
2025-07-01
Recruiting
1,200
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
2015-09-15
2019-08-05
Terminated
1,643
EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)
2016-05-01
2017-07-01
Completed
75

Rows per page:

1–29 of 29

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Boston Center for Memory" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Biogen" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Avid Radiopharmaceuticals" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Boston Center for Memory" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Boston Center for Memory" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 8Eli Lilly and Company: 8Biogen: 4Biogen: 4Hoffmann-La Roche: 3Hoffmann-La Roche: 3AstraZeneca: 2AstraZeneca: 2Avid Radiopharmaceuticals: 2Avid Radiopharmaceuticals: 2Cognito Therapeutics, Inc.: 2Cognito Therapeutics, Inc.: 2Neuronetrix, Inc.: 2Neuronetrix, Inc.: 2Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:2Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:2Alector Inc.: 1Alector Inc.: 1Athira Pharma: 1Athira Pharma: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 3Eli Lilly and Company: 3AbbVie: 1AbbVie: 1Biogen: 1Biogen: 1Boston Center for Memory: 1Boston Center for Memory: 1PRA Health Sciences: 1PRA Health Sciences: 1Premier Research Group plc: 1Premier Research Group plc: 1Premiere Research Institute: 1Premiere Research Institute: 1The Memory Clinic ofVermont: 1The Memory Clinic ofVermont: 1

Clinical Trials Conditions at Boston Center for Memory


According to Clinical.Site data, the most researched conditions in "Boston Center for Memory" are "Alzheimer Disease" (15 trials), "Alzheimer's Disease" (9 trials), "Cognitive Impairment" (4 trials), "Dementia" (3 trials) and "Cognitive Decline" (2 trials). Many other conditions were trialed in "Boston Center for Memory" in a lesser frequency.

Clinical Trials Intervention Types at Boston Center for Memory


Most popular intervention types in "Boston Center for Memory" are "Drug" (25 trials), "Device" (3 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "Donanemab" (3 trials), "Gantenerumab" (3 trials), "Aducanumab" (2 trials) and "LY3202626" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Boston Center for Memory


The vast majority of trials in "Boston Center for Memory" are 29 trials for "All" genders.

Clinical Trials Status at Boston Center for Memory


Currently, there are NaN active trials in "Boston Center for Memory". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Boston Center for Memory, undefined suspended trials, and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Boston Center for Memory, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 10Phase 2: 10Not Applicable: 2Not Applicable: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 8Completed: 8Terminated: 8Terminated: 8Active, not recruiting: 7Active, not recruiting: 7Recruiting: 6Recruiting: 6